Zacks Investment Research on MSN
Recursion Pharmaceuticals to report Q3 earnings: What's in the cards?
Recursion Pharmaceuticals RXRX, a TechBio company, is expected to beat expectations when it reports third-quarter 2026 ...
Hesai Group (Nasdaq: HSAI; HKEX: 2525) ("Hesai" or the "Company"), a Physical AI infrastructure company, today announced that ...
This content was created using generative AI tools. As there is a possibility that the detailed content may contain ...
An integrative analysis of human NOA transcriptomic data and a Utf1 conditional knockout mouse model identifies ACTRT2 and ...
As artificial intelligence rapidly advances from a specialized technology to a force reshaping nearly every aspect of society ...
Anthropic has filed to raise roughly $100 billion at a $1.5–2 trillion valuation — the largest IPO in history by a wide margin. On Peter ...
Anthropic faces intense competitive pressure and huge fixed costs. Can Claude build itself fast enough to succeed?
Gitleaks tutorial: scan git history, block secrets with a pre-commit hook and gate pull requests in GitHub Actions. 12 steps, ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
10月29日消息，近期汇添富多元收益债券C披露2026年第三季度报，基金规模18.76亿元，比2026年第二季度降低55.77%。基金经理马翔最新投资观点同步出炉。 马翔表示，当前权益市场调整属于估值与情绪修正而非产业逻辑逆转，债市在经济弱修复环境下票息收益确定性较强，组合将在严控风险的基础上把握结构性投资机会。 宏观经济： 当前经济修复动能放缓，市场资金面保持平稳运行，配置力量支撑债市整体环境偏 ...
10月29日消息，近期广发成长回报混合A披露2026年第三季度报，基金规模8.45亿元，比2026年第二季度降低34.18%。基金经理刘彬最新投资观点同步出炉。 刘彬表示，当前周期板块上行阶段临近尾声，AI产业长期发展逻辑未变，后续将结合产业趋势调整持仓结构把握结构性机会。 宏观经济： 国内及海外储能需求预期仍较强，四季度电池出口退税取消或将带来一定抢装效应，不过周期上行阶段已接近尾声，相关行业上 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results